Asthma and the risk of invasive pneumococcal disease: a meta-analysis

JA Castro-Rodriguez, K Abarca, E Forno - Pediatrics, 2020 - publications.aap.org
OBJECTIVE: To evaluate the risk of IPD or pneumonia among children with asthma after the
introduction of pneumococcal conjugate vaccines (PCVs). DATA SOURCES: Four electronic …

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - Vaccine, 2019 - Elsevier
Abstract Introduction In 2006, the Netherlands introduced the 7-valent pneumococcal
conjugate vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was …

Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

P Korbal, J Wysocki, T Jackowska, M Kline… - The Pediatric …, 2024 - journals.lww.com
Background: Global pediatric immunization programs with pneumococcal conjugate
vaccines (PCVs) have reduced vaccine-type pneumococcal disease, but a substantial …

Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight …

T Hu, T Weiss, G Bencina… - Journal of Medical …, 2021 - Taylor & Francis
Abstract Aims V114, a 15-valent pneumococcal conjugate vaccine (PCV15) currently
approved in adults in the US, contains the 13 S. pneumoniae serotypes in PCV13 and two …

To LP or not to LP? Identifying the Etiology of Pediatric Meningitis

H Mijovic, M Sadarangani - The Pediatric Infectious Disease …, 2019 - journals.lww.com
Introduction of conjugate vaccines against Haemophilus influenzae type b, Streptococcus
pneumoniae, and Neisseria meningitidis has led to a substantial reduction in cases of acute …

Pneumococcal-related hemolytic uremic syndrome in the United Kingdom: national surveillance, 2006–2016

A Makwana, C Sheppard, NK Fry… - The Pediatric Infectious …, 2019 - journals.lww.com
Background: children< 5 years of age since the introduction of the 7-valent pneumococcal
conjugate vaccine (PCV7) in 2006 and its replacement with the 13-valent pneumococcal …

Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: a …

CH Chen, LH Su, HC Li, MH Hsu, TL Wu, CL Chen… - Vaccine, 2019 - Elsevier
The study aimed to investigate the impact of 13-valent pneumococcal conjugate vaccine
(PCV13) immunization on the overall pneumococcal disease in children in Taiwan by …

Invasive pneumococcal disease in people with human immunodeficiency virus in England, 1999–2017

PD Kirwan, Z Amin-Chowdhury… - Clinical Infectious …, 2021 - academic.oup.com
Abstract Background The 7-valent and 13-valent pneumococcal conjugate vaccines (PCVs)
were introduced into the UK childhood immunization program in 2006 and 2010 …

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era

C Izquierdo, P Ciruela, S Hernández… - Epidemiology & …, 2020 - cambridge.org
The aim was to analyse invasive pneumococcal disease (IPD) serotypes in children aged⩽
17 years according to clinical presentation and antimicrobial susceptibility. We conducted a …

Concurrent bacteremia due to non-vaccine serotype 24F pneumococcus in twins: a rapid increase in serotype 24F-invasive pneumococcal disease and its high …

T Kawabata, Y Tenokuchi, H Yamakuchi… - The Pediatric …, 2020 - journals.lww.com
Although concurrent bacteremia in siblings is rare, serotype 24F Streptococcus pneumoniae
was isolated from the blood of twin 1-year-old girls within a 3-day interval, supporting the …